Featuring an interview with Dr Sagar Lonial, including the following topics:

• KLN-1010: A novel, in vivo gene therapy generating anti-BCMA chimeric antigen receptor T cells (0:00)
• Phase III DREAMM-7 and DREAMM-8 studies of belantamab mafodotin-based combination therapy for patients with relapsed/refractory (R/R) multiple myeloma (MM) (5:37)
• Effectiveness of ciltacabtagene autoleucel for patients with R/R MM (11:04)
• Low-dose tocilizumab for mitigation of the cytokine release syndrome associated with bispecific antibodies (16:04)
• Talquetamab with teclistamab for patients with R/R MM in Phase Ib of the RedirecTT-1 trial (19:24)

CME information and select publications